Statement of Care of Anemia in Delivering Patients at Nord Franche-Comte Hospital
ANEMIA
1 other identifier
observational
1,177
1 country
1
Brief Summary
Anemia is a common pregnancy condition that has multiple origins. Its frequency and severity seem to be increasing, despite the existing management recommendations and the awareness of health professionals. The objective of this study is to make a statement of this pathology within our establishment, to evaluate the proportion of patients presenting this pathology and to highlight possible risk factors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2021
CompletedFirst Posted
Study publicly available on registry
March 24, 2021
CompletedStudy Start
First participant enrolled
April 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 12, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2022
CompletedMarch 16, 2022
March 1, 2021
6 months
March 16, 2021
March 15, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Estimation of the proportion of patients presenting anemia during delivery
Percentage of patients with hemoglobin less than 10.5 g/dl at entry into the delivery room
6 month
Secondary Outcomes (1)
Risk factors underlying anemia during delivery with a large questionnaire
6 month
Interventions
questionnaire post delivery
Eligibility Criteria
All patients presenting eligibility criteria and giving birth at NFC Hospital
You may qualify if:
- \> 18 years
- Delivery at Nord Franche-Comte Hospital
- Delivery ≥ 32 weeks of amenorrhea
- Informed patient and non-opposition of participation
You may not qualify if:
- Protected adults (Patients under guardianship, curatorship, safeguard of justice or under family authorization)
- Medical interruption of pregnancy
- Patients with fetal death in utero or neonatal death
- Minor patients
- Premature delivery before 32 weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Nord Franche-Comté
Trévenans, 90400, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 16, 2021
First Posted
March 24, 2021
Study Start
April 12, 2021
Primary Completion
October 12, 2021
Study Completion
March 15, 2022
Last Updated
March 16, 2022
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share